Investing.com -- Bain Capital is reportedly in negotiations to acquire PCI Pharma Services, according to Bloomberg, citing individuals familiar with the situation. This potential acquisition could be one of the largest private equity takeovers of the year.
The buyout firm is in talks with PCI’s current backers, which include Kohlberg & Co., Mubadala Investment Co., and Partners Group Holding AG. The proposed deal could value the Philadelphia-based drug services provider at over $10 billion, a valuation that includes debt.
An announcement regarding the deal could be made in the coming weeks, as per the sources who wished to remain anonymous due to the confidential nature of the information. However, the ongoing market fluctuations and broader macroeconomic uncertainty could disrupt the negotiations, potentially leaving PCI under its current ownership.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.